blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0761210

EP0761210 - Process for the manufacture of pharmaceutical preparations with controlled release [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.03.2006
Database last updated on 19.10.2024
Most recent event   Tooltip10.03.2006Application deemed to be withdrawnpublished on 26.04.2006  [2006/17]
Applicant(s)For all designated states
Bayer HealthCare AG
51368 Leverkusen / DE
[2004/01]
Former [1997/11]For all designated states
BAYER AG
51368 Leverkusen / DE
Inventor(s)01 / Kanikanti, Venkata-Rangarao, Dr.
Quettinger Str. 24a
51381 Leverkusen / DE
02 / Kettelhoit, Stefan, Dr.
Robert-Medenwald-Str. 5
51375 Leverkusen / DE
03 / Kurka, Peter, Dr.
Schlieperstr. 22
40764 Langenfeld / DE
04 / Penners, Gunther, Dr.
Körnerstr. 6
51373 Leverkusen / DE
05 / Serno, Peter, Dr.
Offenbachstr. 12
51467 Bergisch Gladbach / DE
[1997/11]
Application number, filing date96113158.816.08.1996
[1997/11]
Priority number, dateDE199513168429.08.1995         Original published format: DE 19531684
[1997/11]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP0761210
Date:12.03.1997
Language:DE
[1997/11]
Type: A3 Search report 
No.:EP0761210
Date:28.04.1999
[1999/17]
Search report(s)(Supplementary) European search report - dispatched on:EP11.03.1999
ClassificationIPC:A61K9/22, A61K9/20
[1999/17]
CPC:
A61K9/2054 (EP,US); A61K9/2027 (EP,US); A61K9/2095 (EP,US)
Former IPC [1997/11]A61K9/22
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1997/11]
TitleGerman:Verfahren zur Herstellung von Arzneimittelzubereitungen mit kontrollierter Freisetzung[1997/11]
English:Process for the manufacture of pharmaceutical preparations with controlled release[1997/11]
French:Procédé de fabrication de préparations pharmaceutiques à libération commandée[1997/11]
Examination procedure28.10.1999Examination requested  [1999/52]
21.02.2002Despatch of a communication from the examining division (Time limit: M04)
25.06.2002Reply to a communication from the examining division
31.07.2003Despatch of a communication from the examining division (Time limit: M04)
10.10.2003Reply to a communication from the examining division
08.06.2005Communication of intention to grant the patent
18.10.2005Fee for grant paid
18.10.2005Fee for publishing/printing paid
19.10.2005Application deemed to be withdrawn, date of legal effect  [2006/17]
22.11.2005Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2006/17]
Fees paidRenewal fee
31.08.1998Renewal fee patent year 03
31.08.1999Renewal fee patent year 04
31.08.2000Renewal fee patent year 05
31.08.2001Renewal fee patent year 06
02.09.2002Renewal fee patent year 07
01.09.2003Renewal fee patent year 08
31.08.2004Renewal fee patent year 09
31.08.2005Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]DE4226753  (BASF AG [DE]) [X] 6 * page 5; table 1 *;
 [X]US5009897  (BRINKER DALE R [US], et al) [X] 6 * column 5; example 3 *;
 [X]EP0544144  (BASF AG [DE]) [X] 6 * page 4; example 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.